Search for: "CELGENE"
Results 141 - 160
of 183
Sorted by Relevance
|
Sort by Date
15 Sep 2014, 1:31 pm
In 2010 the drug business, Abraxis, was bought by biotech giant Celgene for $4.5 billion. [read post]
15 Jun 2011, 4:56 am
Lundbeck A/S (IP Whiteboard) (Patentology) Focalin XR (Dexmethylphenidate) – US: Patent infringement complaint filed in response to Para IV certification: Celgene Corp. et al. v. [read post]
19 Feb 2020, 4:03 pm
Indeed, the FTC has required divestitures of on market drugs in Bristol Meyers/Celgene and Amneal/Impax because the Commission generally believes that consumers should not bear the risk that a divestiture may fail. [read post]
30 Nov 2022, 2:13 pm
Matthew L. [read post]
15 Oct 2019, 5:27 pm
., Celgene Corp. v. [read post]
10 Jun 2010, 3:58 am
(Patent Docs) Sitagliptin – Germany: Federal Patent Court referral concerning SPCs: C-125/10 - Merck & Co Inc v Deutsche Patent- und Markenamt (The SPC blog) Thalomid (Thalidomide) – US: Celgene, Barr resolve patent dispute over generic Thalomid (Patent Docs) Ultram (Tramadol) – US: Pharma Products L.P. v. [read post]
4 May 2011, 4:13 am
(Patent Law Practice Center) US: Abraxis files for patent term adjustment calculation review for patent entitled ‘Compositions and methods of delivery of pharmacological agents’ (Patent Docs) US: ITC: Target date set in Certain Vaginal Ring Birth Control Devices (ITC 337 Law Blog) US: Court confused by patent reexamination results: Cellectricon v Fluxion Biosciences (Patents Post-Grant) Products AndroGel (Testosterone) – US: Abbott sues Teva in attempt to block US sales of generic… [read post]
13 Sep 2021, 7:05 am
Celgene Corp., 226 F. [read post]
12 Dec 2008, 7:00 am
EU: European Commission preliminary report on its inquiry into competition in the pharmaceutical sector (Spicy IP) (Intellectual Property Watch) (Patent Baristas) EU: Enlarged Board of the EPO denies WARF’s patent application directed to human embryonic stem cells (Patent Docs) US: Patent Office assault on pharma industry (PLI) US: Proponent of gene patent ban Rep Xavier Becerra to leave Congress (Patent Docs) US: Merck & Co starts generic arm BioVentures to copy biologic medicine… [read post]
16 Jan 2009, 5:00 am
(IP finance) US: Medarex, Eurand and Alexion file actions against Director Dudas seeking revised patent term adjustment determinations (Patent Docs) US: Kubin panel questions motivation behind reversal in new Written Description Training Materials (Patent Docs) US: The obviousness of DNA - Federal Circuit heard oral argument for In re Kubin last week (Patent Docs) Products Antara (Fenofibrate) – US: Oscient and Ethypharm file patent infringement suit against Lupin over Antara… [read post]
25 Jan 2019, 12:00 am
The first being Bristol Myers Squibb Co’s (BMY) acquisition of Celgene Corp. [read post]
14 Jul 2010, 6:47 pm
Cetuximab has its day in Court: Yeda Research and Development Company Ltd v Comptroller General of Patents (SPC blog) Focalin (Dexmethylphenidate) – US: Patent infringement complaint following Paragraph IV certification: Celgene Corp. et al. v. [read post]
25 Aug 2020, 9:41 am
This result comports with the Court’s prior decisions in Celgene Corp. v. [read post]
7 Nov 2008, 3:42 am
Sandoz, Inc (Patent Docs) (PATracer) Boniva (Ibandronic acid) – US: Hoffman La Roche files third patent infringement lawsuit against Orchid over generic Boniva (GenericsWeb) Carbatrol (Carbamazepine) – US: Federal Judge grants summary judgment of noninfringement to Corepharma in Carbatrol patent dispute with Shire Laboratories (Law360) Effexor (Venlafaxine) – US: Wyeth settles with fourth drug company, Anchen Pharmaceuticals, over generic Effexor (Law360) Fentora… [read post]
1 Apr 2012, 3:04 pm
Celgene Corp., 2010 WL 1492869, at *3 (D.N.J. [read post]
1 Mar 2011, 8:38 pm
(FDA Law Blog) Products Abraxane (Paclitaxel) – Global: Elan and Celgene enter into settlement and license agreement related to Abraxane (GenericsWeb) Angiomax (Bivalirudin) – US: The Medicines Company files patent infringement complaint against Mylan following Para IV certification filing (Patent Docs) Aprovel (Irbesartan), Geodon (Ziprasidone) – Brazil: Pipeline system: extending solution is not the same as extending patent validity (IP tango) Fexofenadine –… [read post]
5 May 2010, 4:46 am
(Patent Docs) Intuniv (Guanfacine) – US: Shire files patent suit against Teva over its plans to market generic Intuniv (Patent Quality Review Blog) (Patent Docs) Istodax (Romidepsin) – US: Patent infringement complaint filed in response to Para IV certification: Celgene Corp. v. [read post]
2 Sep 2009, 5:57 pm
: Jacobson v Celgene (Patent Baristas) Ultracet (Tramadol/Acetaminophen) – US: CAFC vacates Ultracet obviousness decision: Ortho-McNeil Pharmaceutical, Inc v Teva Pharmaceuticals (not precedential) (Patently-O) (Patent Docs) (SmartBrief) Viread (Tenofovir) – India: MSF announces Patent Office rejected patents on AIDS drugs Tenofovir and Darunavir (Intellectual Property Watch) [read post]
29 Apr 2019, 3:00 am
’s deal to buy Celgene Corp. [read post]
10 Feb 2010, 4:47 pm
(Patent Docs) Doryx (Doxycycline) – US: Warner Chilcott files patent infringement suit against Sandoz in response to Para IV challenge (Patent Docs) Ebixa (Memantine) – Canada: Duty of good faith patent prosecution: Lundbeck v Ratiopharm (IP Osgoode) Focalin (Dexmethylphenidate) - US: Settlement announced in Focalin infringement dispute involving Celgene, Novartis Pharmaceuticals and Teva Pharmaceuticals (Patent Docs) Gemzar (Gemcitabine) – US: Patent infringement… [read post]
